Copyright Reports & Markets. All rights reserved.

Global Molecular Diagnostics Infectious Disease Testing Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Molecular Diagnostics Infectious Disease Testing Market Status and Forecast (2017-2028)
      • 1.3.2 Global Molecular Diagnostics Infectious Disease Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Molecular Diagnostics Infectious Disease Testing Supply by Company

    • 2.1 Global Molecular Diagnostics Infectious Disease Testing Sales Value by Company
    • 2.2 Molecular Diagnostics Infectious Disease Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Molecular Diagnostics Infectious Disease Testing Market Status by Type

    • 3.1 Molecular Diagnostics Infectious Disease Testing Type Introduction
      • 3.1.1 Bacterial Infectious Disease Testing
      • 3.1.2 Viral Infectious Disease Testing
      • 3.1.3 Parasitic Infectious Disease Testing
    • 3.2 Global Molecular Diagnostics Infectious Disease Testing Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Molecular Diagnostics Infectious Disease Testing Market Status by Application

    • 4.1 Molecular Diagnostics Infectious Disease Testing Segment by Application
      • 4.1.1 Hospital
      • 4.1.2 Laboratory Research
    • 4.2 Global Molecular Diagnostics Infectious Disease Testing Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Molecular Diagnostics Infectious Disease Testing Market Status by Region

    • 5.1 Global Molecular Diagnostics Infectious Disease Testing Market by Region
    • 5.2 North America Molecular Diagnostics Infectious Disease Testing Market Status
    • 5.3 Europe Molecular Diagnostics Infectious Disease Testing Market Status
    • 5.4 Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Status
    • 5.5 Central & South America Molecular Diagnostics Infectious Disease Testing Market Status
    • 5.6 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Status

    6 North America Molecular Diagnostics Infectious Disease Testing Market Status

    • 6.1 North America Molecular Diagnostics Infectious Disease Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Molecular Diagnostics Infectious Disease Testing Market Status

    • 7.1 Europe Molecular Diagnostics Infectious Disease Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Status

    • 8.1 Asia Pacific Molecular Diagnostics Infectious Disease Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Molecular Diagnostics Infectious Disease Testing Market Status

    • 9.1 Central & South America Molecular Diagnostics Infectious Disease Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Status

    • 10.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Type and by Application

    • 12.1 Global Molecular Diagnostics Infectious Disease Testing Sales Value Forecast (2023-2028)
    • 12.2 Global Molecular Diagnostics Infectious Disease Testing Forecast by Type
    • 12.3 Global Molecular Diagnostics Infectious Disease Testing Forecast by Application

    13 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Region/Country

    • 13.1 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Veridex
      • 14.1.1 Company Information
      • 14.1.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.1.3 Veridex Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Thermo Fisher Scientific
      • 14.2.1 Company Information
      • 14.2.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.2.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Siemens AG
      • 14.3.1 Company Information
      • 14.3.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.3.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Qiagen NV
      • 14.4.1 Company Information
      • 14.4.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.4.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Luminex
      • 14.5.1 Company Information
      • 14.5.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.5.3 Luminex Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Genomix Biotech
      • 14.6.1 Company Information
      • 14.6.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.6.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 GenMark Diagnostics
      • 14.7.1 Company Information
      • 14.7.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.7.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 GenMark Diagnostics
      • 14.8.1 Company Information
      • 14.8.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.8.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 F. Hoffmann-La Roche
      • 14.9.1 Company Information
      • 14.9.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.9.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 BioTheranostics
      • 14.10.1 Company Information
      • 14.10.2 Molecular Diagnostics Infectious Disease Testing Product Introduction
      • 14.10.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 bioMérieux
    • 14.12 BD
    • 14.13 Abbott Laboratories

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Molecular Diagnostics Infectious Disease Testing market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Molecular Diagnostics Infectious Disease Testing industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Molecular Diagnostics Infectious Disease Testing market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Molecular Diagnostics Infectious Disease Testing Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics Infectious Disease Testing market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Molecular Diagnostics Infectious Disease Testing Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Molecular Diagnostics Infectious Disease Testing industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Bacterial Infectious Disease Testing
      Viral Infectious Disease Testing
      Parasitic Infectious Disease Testing

      Segmented by Application
      Hospital
      Laboratory Research

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Veridex
      Thermo Fisher Scientific
      Siemens AG
      Qiagen NV
      Luminex
      Genomix Biotech
      GenMark Diagnostics
      GenMark Diagnostics
      F. Hoffmann-La Roche
      BioTheranostics
      bioMérieux
      BD
      Abbott Laboratories
      Buy now